MIRA CONNECT Study: At-Home Urine Test for Pregnancy of Unknown Location

This study is looking at how well an at-home urine test, called the Mira quantitative urine b-hCG test, can measure hormone levels in women with a Pregnancy of Unknown Location (PUL). A PUL means that a pregnancy has been confirmed, but its location (inside or outside the uterus) can't be seen on an ultrasound. The study aims to see if this at-home test can accurately track these hormone levels, potentially reducing the need for frequent clinic visits. You could be eligible if you are a woman between 18 and 40 years old and have been diagnosed with a PUL requiring ongoing monitoring of your hormone levels. The study will compare the at-home test results with standard blood tests over 7 days. The current recruitment status is unclear, and the study plans to enroll 35 participants.

Study design
This is an interventional study, not specifying a phase, and plans to enroll 35 participants (30 with PUL and 5 non-pregnant controls).
What's involved
If you have a PUL, you will perform urine and blood hCG testing starting 24 hours after your initial hCG level. Urine testing will be done at home each morning, limiting water intake for at least 8 hours beforehand.
Compensation
Not stated in the trial record.
Follow-up
Your urine and serum b-hCG levels will be measured for 7 days.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06802263

MIRA CONNECT Study

Recruiting
NAAges 18–40InterventionalDiagnostic
University of Colorado, Denver
~35 participants
Updated 2025-09-16 on ClinicalTrials.gov
What's tested:at-home quantitative urine b-hCG test

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Urine b-hCG
Measured over 7 days
+1 more outcome measured
Pregnancy of Unknown Location (PUL)
1 sites across 1 states
Colorado1

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Non-pregnant
Diagnosed with PUL requiring ongoing surveillance of serum hCG levels

Exclusion

History of renal disease
History of type I or type II diabetes
Known malignancy of any diagnosis including hCG-secreting tumors (hepatobiliary tumors and neuroendocrine tumors) and ovarian germ cell tumors.
Gestational Trophoblastic Disease
Use of hormonal contraception within last 3 months
Patients who work the night shift
History of renal disease
History of type I or type II diabetes
Known malignancy of any diagnosis including hCG-secreting tumors (hepatobiliary tumors and neuroendocrine tumors) and ovarian germ cell tumors.
Gestational Trophoblastic Disease
Unstable patient, concern for ruptured ectopic pregnancy
Initial serum hCG level \> 100,000 mIU/ml
  • Urine b-hCG7 days

    Cases will begin performing urine and serum hCG testing 24 hours after the initial hCG level. Urine hCG testing will be performed on the first morning urine at home and participants will limit water for at least 8 hours before testing. Serum hCG testing will occur at a UCHealth laboratory before 10 am and within 2 hours of the urine test to allow for the comparison of the values. Both urine and serum hCG testing will then occur daily x 7 days, or until a medical or surgical intervention is indicated. If serum testing is indicated on a weekend, patients will present to the UCH Infusion Center. Non-pregnant controls will test the first morning urine at home and undergo serum hCG testing in a UCHealth lab on the 4th and 6th day of the menstrual cycle. All urine hCG values will be recorded in the Mira home kit and evaluated in comparison to serum hCG levels.

  • Serum b-hCG7 days

    Cases will begin performing urine and serum hCG testing 24 hours after the initial hCG level. Urine hCG testing will be performed on the first morning urine at home and participants will limit water for at least 8 hours before testing. Serum hCG testing will occur at a UCHealth laboratory before 10 am and within 2 hours of the urine test to allow for the comparison of the values. Both urine and serum hCG testing will then occur daily x 7 days, or until a medical or surgical intervention is indicated. If serum testing is indicated on a weekend, patients will present to the UCH Infusion Center. Non-pregnant controls will test the first morning urine at home and undergo serum hCG testing in a UCHealth lab on the 4th and 6th day of the menstrual cycle. All urine hCG values will be recorded in the Mira home kit and evaluated in comparison to serum hCG levels.